Your session is about to expire
← Back to Search
Unknown
AB-2004 for Autism Spectrum Disorder
Phase 2
Waitlist Available
Research Sponsored by Axial Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
This trial is testing AB-2004 to see if it can safely and effectively reduce irritability in people with autism spectrum disorder by changing their gut bacteria.
Eligible Conditions
- Autism Spectrum Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: AB-2004Experimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
Axial Therapeutics, Inc.Lead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your condition is considered to be severe by the doctor conducting the screening.I'm sorry, but "Key" is not a valid clinical trial exclusion criterion. Can you please provide more information or context?Your condition is considered severe based on a screening assessment called the Clinical Global Impression - Severity (CGI-S) scale.
Research Study Groups:
This trial has the following groups:- Group 1: AB-2004
- Group 2: Placebo
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger